+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report

Metastatic Cancer Drugs Market By Therapy, By Indication, By Distribution channel: Global Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Metastatic Cancer Drugs Market By Therapy, By Indication, By Distribution channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • June 2023
  • 313 Pages
  • Global
From
Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 116 Pages
  • Global
From
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 161 Pages
  • Global
From
Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 137 Pages
  • Global
From
Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Myc Proto Oncogene Protein (Transcription Factor p64 or Class E Basic Helix Loop Helix Protein 39 or MYC) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 81 Pages
  • Global
From
Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 151 Pages
  • Global
From
Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 125 Pages
  • Global
From
Transforming Growth Factor Beta 1 (TGFB1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Transforming Growth Factor Beta 1 (TGFB1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 112 Pages
  • Global
From
5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021 - Product Thumbnail Image

5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or EC 3.1.3.5) - Drugs in Development, 2021

  • Report
  • November 2021
  • 145 Pages
  • Global
From
Smoothened Homolog (Protein Gx or SMO) - Drugs In Development, 2021 - Product Thumbnail Image

Smoothened Homolog (Protein Gx or SMO) - Drugs In Development, 2021

  • Report
  • December 2021
  • 91 Pages
  • Global
From
Toll Like Receptor 8 (CD288 or TLR8) - Drugs in Development, 2021 - Product Thumbnail Image

Toll Like Receptor 8 (CD288 or TLR8) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Gene Fusion Testing Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028 - Product Thumbnail Image

Gene Fusion Testing Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028

  • Report
  • October 2023
  • 177 Pages
  • Global
From
Smoothened Homolog - Pipeline Review, H1 2020 - Product Thumbnail Image

Smoothened Homolog - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 90 Pages
  • Global
From
Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Drugs in Development, 2021 - Product Thumbnail Image

Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Toll Like Receptor 3 (CD283 or TLR3) - Drugs in Development, 2021 - Product Thumbnail Image

Toll Like Receptor 3 (CD283 or TLR3) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Drugs in Development, 2021 - Product Thumbnail Image

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Indoleamine 2,3 Dioxygenase 1 - Pipeline Review, H2 2020 - Product Thumbnail Image

Indoleamine 2,3 Dioxygenase 1 - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 130 Pages
  • Global
From
Tyrosine Protein Kinase Mer - Pipeline Review, H2 2020 - Product Thumbnail Image

Tyrosine Protein Kinase Mer - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 74 Pages
  • Global
From
Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H1 2020 - Product Thumbnail Image

Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H1 2020

  • Drug Pipelines
  • May 2020
  • 66 Pages
  • Global
From
Tyrosine Protein Kinase CSK - Pipeline Review, H1 2020 - Product Thumbnail Image

Tyrosine Protein Kinase CSK - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 96 Pages
  • Global
From
Loading Indicator